# Pfizer Inc. (PFE): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Pfizer Inc. (PFE) is 83/100, ranked against 24,000+ stocks in 35 markets (Quality 52, Value 61, Momentum 68, each scored against its sector).

- StockRank: 83/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 52, Value 61, Momentum 68: each a 0-100 percentile within Healthcare.
- Position: #4,480 overall, #501 in Healthcare.
- Listing: United States, NYQ; Healthcare / Drug Manufacturers - General.
- Last close: 29.79 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 3.0M; directors sold USD 135K.

Source: https://moatmap.ai/stock/PFE
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker